Federal health officials issued new guidance last week on who should have the COVID-19 vaccine, and it no longer includes ...

Experts say new immunisation program working, but some babies missing outThe number of Australian babies admitted to hospital ...

Moderna has announced FDA approval for its new COVID-19 vaccine, mNexspike (mRNA-1283). This next-generation shot targets a ...

The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...

RSV causes about 100,000 deaths and more than 3.6 million hospitalisations in children under the age of 5 worldwide ...

Just three days into winter and Aussies are already losing their minds over the rapid spread of winter illnesses.

The incidence of RSV across 5 respiratory virus seasons was substantial among adult patients with high-risk underlying conditions.

A Phase III trial demonstrated mNEXSPIKE’s non-inferior efficacy compared with Moderna’s original COVID vaccine, Spikevax.

The results of the non–peer-reviewed research highlight the risk of contracting H5N1 avian flu from unpasteurized dairy ...

ZONO Technologiestm and ZONOSanitechtm are pleased to announce another exciting product line expansion of their patent pending ZONOtm Cabinets. "Our customers value how our solution disinfects+ and ...

Shares of Moderna climbed Monday after the Food and Drug Administration approved a new COVID-19 vaccine from the drugmaker.

FDA approves Moderna’s mNEXSPIKE COVID-19 vaccine for high-risk groups Phase 3 trial shows mNEXSPIKE outperforms original ...